BE 

BE 

Women in blue in front of blue door

BE 
the cure

BrightEdge exists to accelerate the American Cancer Society’s mission: a world without cancer.

Learn More

BE 
the model

A philanthropic impact fund investing donations in for-profit companies bringing innovative, cancer-focused therapies and technologies to market.

Learn More
Women smiling in a field

BE 
the impact

BE capital and resources deliver patients access to today’s most promising ways to save lives, celebrate lives, and lead the fight for a world without cancer.

Learn More
Women in blue in front of blue door
Women smiling in a field

News

BrightEdge, American Cancer Society's Newly Formed Philanthropic Impact Fund, Announces First Investment

Convertible note investment in Castle Biosciences Inc., an innovator in skin-cancer diagnostics, is first deal for BrightEdge Impact Fund

BrightEdge Managing Director to Participate in SEC Roundtable to Kick Off National Small Business Week

FOR IMMEDIATE RELEASE 2019-63 Washington D.C., April 30, 2019 — The Securities and Exchange Commission today announced that its Office of the Advocate for Small Business Capital Formation will host a roundtable on May 6 to hear from small businesses and their investors. The roundtable will celebrate the kickoff of National Small Business Week, which is May 5-11.

In Quest for Cures, Medical Nonprofits Seek to Wield Their Own Venture Funding Power

The Wall Street Journal included BrightEdge in a look at the emergence of philanthropic venture funds to provide capital to medical startups. Bob Crutchfield, managing director of the BrightEdge fund, says such nonprofit funding vehicles nicely complement the role of the for-profit capital markets in accelerating the time it takes for promising healthcare innovations to get from patient trials to commercialization.
See All News